Caraco Denied Quick Win On Prandin IP Misuse Claim
A federal judge in Michigan on Thursday refused to analyze Caraco Pharmaceutical Laboratories Ltd.'s contention that Novo Nordisk A/S misused its patent for the diabetes drug Prandin, finding the matter inappropriate...To view the full article, register now.
Already a subscriber? Click here to view full article